June 20, 2023: U.S. Patent No. 11,679,123 "N-Acylated Hyaluronic Acid for Hyperuricemia and Gouty Arthritis"

Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,679,123 entitled, "N-Acylated Hyaluronic Acid for Hyperuricemia and Gouty Arthritis," on June 20, 2023 to Yin Gao and Tassos Anastassiades. The patent relates to a pharmaceutical composition of hyaluronic acid for the treatment of hyperuicemia and gouty arthritis.

U.S. Patent No. 11,679,123 (PDF, 2.5 MB)